US6680197B2

Compositions and methods for the therapy and diagnosis of breast cancer

Summary by NHIP

Polynucleotide breast cancer diagnostics

The invention provides isolated polynucleotides, probes, and kits utilizing SEQ ID NO:463 for breast cancer diagnosis. Distinctive elements include the specific sequence SEQ ID NO:463 and probes comprising at least 10 contiguous nucleotides of this sequence or its complement.

Claim Score by NHIP

Read claim 1, the broadest

Abstract

Compositions and methods for the therapy and diagnosis of cancer, particularly breast cancer, are disclosed. Illustrative compositions comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly breast cancer.

US6680197B2, drawing sheet 1
Sheet 1 of 2

Term

Term ended

Expired 28 April 2019, 7.4 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

6 claims: 2 independent, 4 dependent

  1. 1
    Broadest claimClaim Score 95, very broad(NHIP)An isolated polynucleotide selected from the group consisting of (a) a polynucleotide sequence comprising SEQ ID NO:463, and (b) the complement of (a).
  2. 3
    A composition comprising a first component selected from the group consisting of physiologically acceptable carriers and immunostimulants, and a second component comprising SEQ ID NO:463.